This document was developed to provide practical guidance on interpretation of the most commonly used first- and second-line line probe assays (LPAs). In this updated manual, the interpretation of mutations identified by the assays has been revised to align with the WHO catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance. It also presents the latest changes in instructions for use of the assays. In addition, the manual provides support for staff at national and regional TB reference laboratories in understanding and managing any discrepancies between phenotypic and genotypic drug susceptibility testing.
Entire content available on: https://www.who.int/publications-detail-redirect/9789240046665
Lingua
IngleseTipologia
Linee guidaArgomento
Laboratorio Microbiologia Resistenza Antimicrobica (AMR) TubercolosiProfilo
Staff tecnico HCWPaese
USA Canada America del sud America centrale Caraibi Medio oriente Sud Pacifico Cina India Indocina Singapore Europa e UK Oceania Africa